Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients | MicrobiomeTrials← Back to trialsNCT07634978
Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-01-01Est. Completion: 2026-08-01
Enrollment target: 150 participants Locations- Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China
Other microbiome trials you might be interested in
Diabetes Mellitus, Type 2HypertensionCardiovascular Diseases
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the …
Anniston, United StatesEst. completion Dec 14, 2029
Advanced Malignant Solid Tumors
This Phase I/II study evaluates the safety, tolerability, and efficacy of N-3C01 administered subcutaneously, both as mo…
Saint Leonards, AustraliaEst. completion Aug 31, 2028
MelanomaGliomaThyroid CancerNon-Small Cell Lung CancerMalignant NeoplasmsBrain NeoplasmsAdvanced or Metastatic Solid TumorsHGGLGGLow Grade GliomaHigh Grade GliomaDifferentiated Thyroid CancerNSCLC (Non-small Cell Lung Cancer)
The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in co…
Birmingham, United StatesEst. completion Aug 2, 2027